- Pagina principale
- Analisi delle app
- DxScript
- DxScript Vs. EPrescribeMD
DxScript vs. EPrescribeMD Utilizzo e statistiche
DxScript® ePrescribing service puts eligibility, benefits, and formulary information at your fingertips at the time of prescribing. This enable prescriber to select medications that are on formulary and are covered by the patient's drug benefit. It also informs you of lower cost alternatives such as generic drugs.
Prescriber can access a timely and clinically sound view of a patient's prescription history across providers, at the point of care. This decreases the risk of preventable medication errors.
DxScript® replaces old, error-phone approach to writing. Printing new prescription electronically in your office reduces the risk of medication errors associated with poor handwriting, illegible faxes and manual data entry. Using DxScript® to process prescription renewals saves you time and money by dramatically reducing the number of phone calls and faxes typically associated with the prescription renewal authorization process.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
The ePrescribeMD is the latest app to be launched by HospiceMD Inc. The app is primarily for doctors. They can now review and e-prescribe medications as well as approve agencies via the App.
The App is solely meant as a tool to send out e-prescriptions and needs to be used in tandem with the HospiceMD website. Therefore, e-prescriptions and agency request are only populated if they are entered via the site.
- App Store di Apple
- Gratis
- Salute e fitness
Classifica degli store
- -
DxScriptRanking a confronto con EPrescribeMD
Confronta la tendenza di classifica DxScript nei ultimi 28 giorni rispetto a EPrescribeMD
Rank
Nessun dato disponibile
Classifica DxScript vs. EPrescribeMD per paese a confronto
Confronta la tendenza di classifica DxScript nei ultimi 28 giorni rispetto a EPrescribeMD
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
DxScript VS.
EPrescribeMD
14icembre d, 2024